0001144204-15-006190.txt : 20150205 0001144204-15-006190.hdr.sgml : 20150205 20150205135524 ACCESSION NUMBER: 0001144204-15-006190 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150205 DATE AS OF CHANGE: 20150205 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Ocata Therapeutics, Inc. CENTRAL INDEX KEY: 0001140098 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 870656515 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-79462 FILM NUMBER: 15579413 BUSINESS ADDRESS: STREET 1: 33 LOCKE DRIVE CITY: MARLBOROUGH STATE: MA ZIP: 01752 BUSINESS PHONE: 508-756-1212 MAIL ADDRESS: STREET 1: 33 LOCKE DRIVE CITY: MARLBOROUGH STATE: MA ZIP: 01752 FORMER COMPANY: FORMER CONFORMED NAME: ADVANCED CELL TECHNOLOGY, INC. DATE OF NAME CHANGE: 20050623 FORMER COMPANY: FORMER CONFORMED NAME: A.C.T. Holdings, Inc. DATE OF NAME CHANGE: 20050303 FORMER COMPANY: FORMER CONFORMED NAME: A.C.T Holdings, Inc. DATE OF NAME CHANGE: 20050207 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Aronson Gary D CENTRAL INDEX KEY: 0001376796 FILING VALUES: FORM TYPE: SC 13G/A MAIL ADDRESS: STREET 1: 774 MAYS BOULEVARD 10-PMB 128 CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 SC 13G/A 1 v400504_13ga.htm FORM SC 13G/A

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C 20549

 

Schedule 13G/A

 

Under the Securities Exchange Act of 1934

(Amendment No. 1)

 

  OCATA THERAPEUTICS, INC.
  (Name of Issuer)  

 

 

  COMMON STOCK, $.001 PAR VALUE
  (Title of Class of Securities)  

 

  67457L100  
  (CUSIP Number)  

 

December 31, 2014    
  (Date of Event which Requires Filing This Statement)  

 

Check the appropriate box to designate the Rule pursuant to which this Schedule is filed.

 

¨Rule 13d-1(b)
xRule 13d-1(c)
¨Rule 13d-1(d)

 

*The remainder of this cover page shall be filed out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

Page 1 of 4
 

 

Schedule 13G

 

CUSIP No. 67457L100

 

1.NAME OF REPORTING PERSON

 

GARY D. ARONSON

 

2.CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP.

 

(a) xx

(b)

 

3.SEC USE ONLY

 

4.CITIZENSHIP OR PLACE OF ORGANIZATION

 

U.S.A.

 

NUMBER OF 5. SOLE VOTING POWER: 2,150,044
SHARES    
BENEFICIALLY 6. SHARED VOTING POWER: -0-
OWNED BY      
EACH REPORTING 7. SOLE DISPOSITIVE POWER: 2,150,044
 PERSON WITH      
  8. SHARED DISPOSITIVE POWER:    -0-

 

 

9.AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

 

2,150,044

 

10.CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

 

 

 

11.PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

 

6.2%

 

12.TYPE OF REPORTING PERSON

 

IN

 

Page 2 of 4
 

 

Item 1(a) Name of Issuer:  Ocata Therapeutics, Inc.  
     
Item 1(b) Address of Issuer's Principal Executive Offices:  
  33 Locke Drive, Marlborough, MA 01752  
     
Item 2(a) Name of Person Filing:  Gary D. Aronson  
     
Item 2(b) Address: 774 Mays Blvd. 10-PMB-128, Incline Village, NV 89451  
Item 2(c) Citizenship:  U.S.
     
Item 2(d) Title of Class of Securities:  Common Stock  
     
Item 2(e) CUSIP Number:  67457L100  
     
Item 3 Statement filed Pursuant to §240.13d-1(b) or 240.13d-2(b) or (c):  Not applicable.  
     
Item 4 Amount Beneficially Owned; Percent of Class:  The reporting person beneficially owns 2,150,044 shares of the issuer’s common stock, which represents 6.2% of the 34,612,718 shares outstanding as of November 30, 2014, as reported by the Issuer in a Rule 424B5 Prospectus filed on December 2, 2014.  
     
  The reporting person is a member of a group with John Gorton, an individual (IN).  
     
  For information regarding the number of shares as to which the reporting person has voting and dispositive power as of December 31, 2014, see Items 5 through 8 of page 2, which are incorporated herein by this reference.  
     
Item 5 Ownership of Five Percent or Less of a Class:  If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [].  
     
Item 6 Ownership of More than Five Percent on Behalf of Another Person:  Not applicable  
     
Item 7 Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:  Not applicable  
     
Item 8 Identification and Classification of Members of the Group:  Not applicable.  
     
Item 9 Notice of Dissolution of Group:  Not applicable  
     
Item 10 Certification:  By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.  

 

Page 3 of 4
 

 

SIGNATURE

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: February 4, 2014 /s/ Gary D. Aronson
  Gary D. Aronson

 

Page 4 of 4